Key Takeaways
- Leeds Teaching Hospitals NHS Trust has implemented Annalise.ai’s AI chest X-ray solution to enhance diagnosis efficiency.
- The software identifies up to 85 findings in chest X-rays, aiding in urgent clinical decision-making.
- Backed by NHS funding, the AI solution will soon be available across six imaging networks in England for improved early detection of conditions like lung cancer.
AI Enhancing Patient Care at Leeds Teaching Hospitals
Leeds Teaching Hospitals NHS Trust (LTHT) has integrated Annalise.ai’s AI chest X-ray solution to improve diagnostic speed and enhance patient care. Annually, LTHT conducts over 135,000 chest X-rays, essential for urgent clinical decisions. This AI tool, which went live in May 2025, serves as a ‘second pair of eyes’ for clinicians, identifying up to 85 different findings, including signs of lung cancer and acute infections, with results delivered within minutes.
According to Dr. Fahmid Chowdhury, a consultant radiologist and project lead, the technology prioritizes patient care. It enables busy frontline staff to accurately and quickly detect serious conditions, thus facilitating timely treatment. Large-scale evaluations of AI in clinical practice are expected to generate valuable insights for advancing patient care quality.
The initiative is supported by the NHS AI Diagnostic Fund and executed through the Yorkshire Imaging Collaborative. LTHT has also collaborated with the vendor-neutral platform Newton’s Tree to implement Annalise’s solution effectively. This AI tool is anticipated to enhance patient safety by promptly identifying critical conditions such as chest sepsis, reducing the likelihood of avoidable complications.
Annalise.ai’s technology is robust, capable of detecting up to 124 findings on chest X-rays and 130 findings on non-contrast head CT scans. The system can be customized for various clinical scenarios and settings. Dr. Aengus Tran, co-founder and CEO of Annalise.ai, expressed enthusiasm for the collaboration, emphasizing their commitment to improving diagnostic accuracy and efficiency within the NHS using advanced technologies.
In May 2024, six imaging networks in England selected Annalise.ai as their preferred provider for early lung cancer diagnosis under the NHS AI Diagnostic Fund. This £21 million fund, announced by NHS England in June 2023, aims to accelerate the adoption of AI and machine learning tools for the prompt diagnosis and treatment of serious health issues, including cancer and heart conditions.
Through successful bids under the AI Diagnostic Fund, Annalise.ai’s chest X-ray tool will be accessible to radiologists in several networks, including the Greater Manchester Imaging Network and the North East and North Cumbria Imaging Network, among others. This widespread deployment signifies a major step forward in leveraging AI to enhance healthcare delivery in the NHS and improve patient outcomes across England.
The content above is a summary. For more details, see the source article.
